This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Methods used to judge relevance and validity, and for extracting data
Summary statistics from individual studies.
Number of primary studies included
At least 12 studies were included.
Methods of combining primary studies
Narrative method.
Investigation of differences between primary studies
Not stated.
Results of the review
For patients who had just experienced a reversible cerebral event, the risk of an irreversible stroke in the following month was 4.4%. If a stroke did not occur in the following month, then the annual risk of an irreversible stroke was 13%, and the annual risk of a reversible event was 14.5%. For patients who had just experienced an irreversible stroke, the risk of cerebrovascular death in the following month was 17%. If death did not occur, then the annual risk of another irreversible stroke was 14%. For patients with uncomplicated surgeries, the relative risk reduction attributable to surgery was 73% for asymptomatic patients and 80% for symptomatic patients. These risk reductions persisted over the patient's life. Conventional angiography was 100% sensitive and specific. The combined frequency of tandem lesions and/or cerebral aneurysms was 5%. The accuracy of 3D MRA for detecting these lesions was as follows: sensitivity, 80%; specificity, 95%. The frequency of patients with claustrophobia or metal devices that contraindicated MRA was 5%. The short-term morbidity associated with surgery was equivalent to a 1-week reduction in qualityadjusted survival. 20% of patients with transient ischemic attacks (TIAs) required hospital admission. For transient cerebral events the mean utility was 0.8 and 58% of utilities were between 0.7 and 0.9. The median duration of a transient event was 1 day, and 95% of durations were less than 2 weeks.
Measure of benefits used in the economic analysis
Quality-adjusted life years (QALYs) were used as the measure of benefits. Utilities were discounted at an annual rate of 5%.
Direct costs
Direct costs were discounted at an annual rate of 5%. Quantities and costs were reported separately. Direct costs covered direct professional and technical costs of diagnostic imaging and surgery. The quantity/cost boundary adopted was that of the hospital. The estimation of quantities and costs was based on actual data. Cost data were collected from the authors' institution. The price year was 1995.
